Patent Grant
11642458
This is a nonprovisional patent application of U.S. Provisional Patent Application No. 62/940,596, filed Nov. 26, 2019, and titled INFUSION AND BLOOD COLLECTION DEVICES AND METHODS, which is incorporated herein by reference.
The present invention relates to an infusion and blood collection device and method. In particular, the present invention is directed to an infusion and blood collection device that allows clean blood collections via an angiocatheter previously installed to administer intravenous fluids. The present invention is also directed to a method of using the infusion and blood collection device to draw blood from a patient via a previously installed angiocatheter.
U.S. Pat. No. 3,610,226 to Albisser discloses a double lumen cannula instrument for the withdrawal of blood over a prolonged period of time. The instrument includes an inner lumen for withdrawing blood and an outer lumen for introducing an anticoagulant diluent. The relative locations of the openings for the inner and outer lumen permit the mixing of the diluent with the withdrawn blood.
U.S. Pat. No. 5,374,245 to Mahurkar discloses an extruded reinforced multiple-lumen catheter for use in medical applications where fluids must flow simultaneously to and from a patient. Blood is withdrawn for a medical procedure (for example, dialysis) from the patient through one passageway and returned to the patient through another passageway spaced from the first passageway.
U.S. Pat. No. 5,607,401 to Humphrey discloses augmented polymeric hypodermic needles and lancets. The polymeric needles and lancets are stiffened by augmenting means, which includes a slidable guard or foam insert so that they are able to pierce the skin. Without the augmenting means, it is not possible for the polymeric hypodermic lancet to pierce the skin.
U.S. Pat. No. 5,637,399 to Yoshikawa et al. discloses an extruded synthetic resin needle that is reinforced with combustible fibers. The needle provides a single path administering or withdrawing fluids from a patient.
The prior art described above does not provide for a catheter assembly that is capable of prolonged insertion in the patient for both the simultaneous administering of intravenous fluids and the periodic withdrawal of blood without mixing the intravenous fluid with the withdrawn blood.
U.S. Pat. No. 6,758,835 to Close et al. discloses a micro-injection molded disposable needle assembly having more than one passageway formed therein to permit the simultaneous drawing and administering of fluids through separate passageways. The micro-injection molded disposable assembly includes one or more sensors disposed therein for measuring and monitoring one or more desired body or surrounding environmental conditions. It also discloses a method of forming the disposable needle from an elastomeric material using micro-injection molding.
The invention herein is partly an extension of the device and method disclosed in U.S. Pat. No. 6,758,835 to Close et al. Accordingly, the disclosure of U.S. Pat. No. 6,758,835 is incorporated herein by reference in its entirety.
The devices described in the above prior art focus primarily on the catheter portions of needle assemblies that are capable of prolonged insertion in patients for both the simultaneous administering of intravenous fluids and the withdrawal of blood without mixing the intravenous fluid with the withdrawn blood.
Unlike the above prior art, the invention herein does not focus primarily on the catheter portion of the needle assembly. Instead, it provides a device that may be inserted between a standard, previously installed intravenous (IV) catheter (for example, a peripheral venous catheter) and a standard IV infusion line, and permits the performing of clean blood collections without interrupting the administering of IV therapy to the patient. For example, IV infusion pumps are typically stopped for 30 seconds or more for any blood collection obtained from the peripheral catheter and the connection between the IV catheter and infusate line are disconnected in order to pull the blood sample through the IV catheter and avoid infusate mixing with the blood collection that can cause erroneous results. If the IV infusion pump is not stopped and a downstream valve (for example, a 2-, 3-, or 4-way stop cock valve) is used to stop the infusate administration, then a pump alarm is set off, requiring staff attention because the line is considered occluded. Such fluid infusion restriction alarms on IV infusion pumps are typically triggered when the fluid being infused increases to over 10 psi. Providing a device that avoids interruption of the IV therapy prevents stopping the IV infusion pump or triggering an infusion restriction alarm. Further, the device herein has the purpose of reducing the complexity of the flow transfer portion of commonly used infusates and blood collection devices. Thus, whereas in some of the above prior art the pressure is sensed and controlled actively to ensure a clean blood collection, in the instant invention, the pressure can be controlled passively, or alternatively or additionally, actively.
When a patient is admitted into a hospital, an emergency room, or some other medical facility, in the vast majority of cases the patient receives an IV catheter of one kind or another. In some instances, the IV catheter is put in place right away upon admission to administer a needed therapy to the patient. In other instances, the IV catheter is put in place simply for risk management reasons, so as to have the catheter ready in case the medical care providers need to quickly administer medications or fluids to the patient. The cannula portion of the IV catheter is placed into a blood vessel, typically in the forearm, hand, or another location in the patient's body (that is, any animal body, for example, a human, canine, feline, equine, etc.), and the connection portion of the IV Catheter to allow IV infusion is typically secured to the outside of the patient's body with any of a variety of available tapes, bands, straps, or other means.
The typical hospital stay for a patient, on average, is around three days, during which it is reported that two or more sets of laboratory tests per day may be carried out on average. This means that at least twice a day a medical technician would have to subject the patient to a blood collection, which is then sent to the laboratory for testing and/or analysis. Usually if the patient already has a catheter strapped in place in one arm via which medications or fluids are being administered, the medical technician would have to use the patient's other arm or another part of the patient's body to perform blood collections. This means that, during a patient's 3-day average hospital stay, there are at least six occasions for the patient to be repeatedly stuck with a needle, which translates into at least six occasions for potential infections to start, hematomas, missed sticks, and skin irritation from tapes and other means. Furthermore, especially in situations involving pediatric patients, hemophiliac patients, HIV patients, patients with dementia and/or similar conditions, and/or other agitated patients who may suffer from fear of needle pricks, or having other elevated risks relating to additional needle insertions, the patient may be subjected to trauma on at least six occasions during their hospital stay, making the blood collection process difficult or otherwise risky.
Moreover, in some situations, the medical technician may use a catheter already installed into the patient's body to draw blood for testing. In those situations, the technician typically has to temporarily discontinue administration of medications or fluids, and perform a lengthy, drawn-out series of flushing steps to guard against incidental contamination of the blood sample with residual IV solutions, medications or fluids, and ensure that the blood sample is clean. Without such flushing steps, a blood sample may, for example, be diluted with a residual IV solution, leading to erroneous test results. Likewise, for example, contamination of the blood sample with a residual IV solution that contains sodium and/or potassium compounds, would result in false test data showing higher concentrations of these compounds.
As will become apparent in the following disclosure, it is believed that the device and method of the invention described herein provide the advantage of alleviating and solving all of the foregoing blood-draw problems and issues. The device herein takes advantage of an already installed IV catheter port in a patient's body, and provides a simple procedure to perform clean drawing of blood without interrupting the administration of IV therapies after initial installation of the catheter. The device optionally includes passive control of the blood collection volume flow rate to prevent contamination of the collected blood draw with the IV therapy fluid being simultaneously infused through the catheter. The device herein is simply installed by inserting it into the IV catheter line already installed into the patient, and makes the procedural steps of drawing blood samples almost automatic. Furthermore, the device herein has the advantage of using the vacuum within a standard blood collection container, such as a Vacutainer® (trademark of Becton, Dickinson and Company, of Franklin Lakes, N.J.) or Vacuette® (trademark of Greiner Bio One, of Monroe, N.C.) tube, as the driving mechanism for drawing the blood sample from the patient.
In an illustrative embodiment of the device (with distal/proximal references to the device, not the patient's body), a medical tube (for example, a microlumen) is inserted coaxially through and protrudes distally out from the distal end of another medical tube (for example, a catheter) which is inserted into a patient. The microlumen and catheter are in fluid communication with a diverter valve and valve housing. The valve housing is supplied with IV therapy fluid from an infusion line and provides selective operation in an infusion/non-collection mode and an infusion/collection mode. In the infusion/non-collection mode, IV therapy fluid is provided to both the microlumen and the catheter. In the infusion/collection mode, a blood collection component, for example, a vacuum collection tube holder coupled to the collection body, receives blood from the catheter and the microlumen simultaneously continues to provide IV therapy fluid to the patient.
The protrusion length and blood collection flow rate are of significant importance to the invention herein, in order to prevent mixing, and thus contamination, of the drawn blood with the IV fluids in the infusion/collection mode. For example, the difference in pressures between a vacuum blood collection tube and a typical patent's vein pressure is approximately 2 orders of magnitude difference. For example, the tube vacuum can be as much as about 700 mmHg of vacuum and the vein pressure can be about 7 mmHg. Thus, the mixing of collected blood with IV fluids at the point of collection in the vein is prevented by a combination of 1) the device limiting the flow rate of blood collection drawn from the vein and into the catheter and 2) the distal end of the microlumen used to simultaneously infuse infusate into the vein is sufficiently distal in the vein of the distal end of the IV catheter where blood is drawn from the vein.
While the illustrative embodiment of the instant invention is directed to an angiocatheter (that is, an IV catheter), it is to be understood that, as contemplated herein, the invention may be applicable to other catheters known in the art as well, such as peripherally inserted cardiac catheters, central catheter, and the like.
It is an object of the present invention to provide an infusion and blood collection device that allows clean blood collections from a patient via a previously installed catheter, such as a Peripheral Venous Catheter, otherwise known as an angiocatheter, without interrupting the administration of intravenous therapies after the initial installation.
It is another object of the present invention to provide an infusion and blood collection device that allows clean blood collections from a patient via a previously installed catheter, without having to resort to repeatedly sticking a patient with a needle at another location of their body away from the already installed catheter.
It is another object of the present invention to provide an infusion and blood collection device that allows clean blood collections from a patient via a previously installed catheter, without exposing the patient to a higher risk of infection from repeated and multiple needle pricks.
It is another object of the present invention to provide an infusion and blood collection device that allows clean blood collections from a patient via a previously installed catheter, wherein the patient is a pediatric patient, a hemophiliac patient, a HIV patient, a patient with dementia and/or a similar condition, and/or any patient who may be agitated or suffer from fear of needle pricks, or having other elevated risks relating to additional needle insertions.
It is another object of the present invention to provide an infusion and blood collection device that allows clean blood collections from a patient via a previously installed catheter, without the need to temporarily discontinue administration of medications or fluids, and performing a lengthy, drawn-out series of flushing steps to guard against incidental contamination of the blood sample with residual IV solutions, medications or fluids.
It is another object of the present invention to provide an infusion and blood collection device that allows clean blood collections from a patient via a previously installed catheter, in such a manner so as to reduce the time and patient care demands of hospital staff.
The present invention relates to a blood-draw device and method that is used in conjunction with a pre-installed peripheral venous catheter/IV infusion line in a patient. An advantage of the device and method is being able to draw blood from the previously installed catheter without the need to interrupt IV flow.
Another advantage of the device and method is the reduction in the number of venipunctures that have to be performed on a patient. This provides numerous potential advantages such as reduction in potential infection causing events, reduction in patient anxiety, reduction in time and patient care demands on the hospital staff, and reduction in disposal of bio-hazardous blood collection needle sets.
Another advantage is having the blood collection access port of the device covered so as to prevent tampering with the port and bacterial transfers from the outside environment, which may either contaminate or damage the port, which in turn may lead to bodily injury.
One illustrative embodiment of an infusion and blood collection device for use with a patient catheter and an IV infusion line providing IV therapy fluid to the patient comprises a blood collection component having a draw inlet; a housing having an actuator and an IV infusion inlet coupled to the IV infusion line, the actuator enabling at least an infusion/non-collection mode of operation and an infusion/collection mode of operation for the device; a microlumen collocated with the patient catheter, the microlumen in fluid communication with the IV infusion inlet; a blood collection channel in fluid communication with the catheter, the blood collection channel directly accessible by the draw inlet of the blood collection component; and wherein in the infusion/non-collection mode the actuator fluidly couples the blood collection channel with the IV infusion inlet, and in the infusion/collection mode the actuator fluidly isolates the blood collection channel from the IV infusion inlet.
The blood collection channel can be self-flushing with IV therapy fluid in the infusion/non-collection mode. The device can further comprise a passive restriction device limiting the volume flow rate of blood drawn by the catheter in the infusion/collection mode, thereby preventing mixing of the blood draw with IV therapy fluid provided through the microlumen. The blood collection component can be releasably attachable to the housing. The actuator can be actuated to the infusion/collection mode by engagement of the blood collection component with the housing and the actuator is actuated to the infusion/non-collection mode by disengagement of the blood collection component with the housing. The engagement can include axial and rotational movement of the blood collection component relative to the housing, the axial movement placing the draw inlet in fluid communication with the blood collection component and the rotation movement operating the actuator.
The draw inlet can include a needle positionable to extend into the blood collection channel in the infusion/collection mode. The blood collection component can fluidly couple a vacuum blood collection tube to the blood collection channel. The actuator can include a rotary valve. The rotary valve can be a two-way valve having two open ports and a third selective port, the valve defines at least a portion of the blood collection channel. The draw inlet of the blood collection component can be extendable through the third selective port into the portion of the blood collection channel defined by the rotary valve. The microlumen can extend past the distal end of the catheter such that a distal end of the microlumen is located distally beyond the distal end of the catheter. The microlumen can be threaded coaxially through the catheter. The patient catheter can include a fluid catheter connector. The housing can include a fluid head connector for coupling to the catheter connector. The microlumen can exit the housing from within the head connector. The blood collection channel can be in fluid communication with the head connector.
Another illustrative embodiment of an infusion and blood collection device for use with a patient catheter and an IV infusion line providing IV therapy fluid to the patient, comprises a blood collection component; a housing having an actuator and an IV infusion inlet coupled to the IV infusion line, the actuator enabling at least an infusion/non-collection mode of operation and an infusion/collection mode of operation for the device; a microlumen collocated with the patient catheter, the microlumen in fluid communication with the IV infusion inlet; a blood collection channel in fluid communication with the catheter; and a passive restriction device limiting the volume flow rate of blood drawn by the catheter in the infusion/collection mode, thereby preventing mixing of the blood draw with IV therapy fluid provided through the microlumen; and wherein in the infusion/non-collection mode the actuator fluidly couples the blood collection channel with the IV infusion inlet, and in the infusion/collection mode the actuator fluidly isolates the blood collection channel from the IV infusion inlet.
The passive restriction device can be a thin, elongate tube fluidly coupling the blood collection component and blood collection channel. The microlumen can be positioned coaxially within the catheter and the distal end of the microlumen extend distally beyond the distal end of the catheter. The blood collection component can fluidly couple a vacuum blood collection tube to the blood collection channel. The blood collection component can be releasably attachable to the housing. The actuator can be actuated to the infusion/collection mode by engagement of the blood collection component with the housing and the actuator can be actuated to the infusion/non-collection mode by disengagement of the blood collection component with the housing. The engagement can include axial and rotational movement of the blood collection component relative to the housing, the axial movement placing the elongate tube in fluid communication with the blood collection component and the rotation movement operating the actuator.
Yet another illustrative embodiment of an infusion and blood collection device for use with a patient catheter and an IV infusion line providing IV therapy fluid to the patient, comprises a housing having an actuator and an IV infusion inlet coupled to the IV infusion line, the actuator enabling at least an infusion/non-collection mode of operation and an infusion/collection mode of operation for the device; a microlumen positionable coaxially through the patient catheter, the distal end of the microlumen extending distally beyond the distal end of the catheter the microlumen, and the microlumen in fluid communication with the IV infusion inlet; a blood collection channel in fluid communication with the catheter; and a blood collection tube holder releasably attachable to the housing and having a draw needle, the draw needle selectively in fluid communication with the blood collection channel in the infusion/collection mode, and the draw needle providing a restriction limiting the volume flow rate of blood drawn by the catheter in the infusion/collection mode, thereby preventing mixing of the blood draw with IV therapy fluid provided through the microlumen; and wherein in the infusion/non-collection mode the actuator fluidly couples the blood collection channel with the IV infusion inlet, and in the infusion/collection mode the actuator fluidly isolates the blood collection channel from the IV infusion inlet.
The detailed description particularly refers to the accompanying figures in which:
For the purposes of promoting an understanding of the principles of the disclosure, reference will now be made to one or more embodiments, which may or may not be illustrated in the drawings, and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the disclosure is thereby intended; any alterations and further modifications of the described or illustrated embodiments and any further applications of the principles of the disclosure as illustrated herein are contemplated as would normally occur to one skilled in the art to which the disclosure relates. At least one embodiment of the disclosure is shown in great detail, although it will be apparent to those skilled in the relevant art that some features or some combinations of features may not be shown for the sake of clarity.
Any reference to “invention” within this document is a reference to an embodiment of a family of inventions, with no single embodiment including features that are necessarily included in all embodiments, unless otherwise stated. Furthermore, although there may be references to benefits or advantages provided by some embodiments, other embodiments may not include those same benefits or advantages, or may include different benefits or advantages. Any benefits or advantages described herein are not to be construed as limiting to any of the claims.
Likewise, there may be discussion with regards to “objects” associated with some embodiments of the present invention, it is understood that yet other embodiments may not be associated with those same objects, or may include yet different objects. Any advantages, objects, or similar words used herein are not to be construed as limiting to any of the claims. The usage of words indicating preference, such as “preferably,” refers to features and aspects that are present in at least one embodiment, but which are optional for some embodiments.
Specific quantities (spatial dimensions, temperatures, pressures, times, force, resistance, current, voltage, concentrations, wavelengths, frequencies, heat transfer coefficients, dimensionless parameters, etc.) may be used explicitly or implicitly herein, such specific quantities are presented as examples only and are approximate values unless otherwise indicated. Discussions pertaining to specific compositions of matter, if present, are presented as examples only and do not limit the applicability of other compositions of matter, especially other compositions of matter with similar properties, unless otherwise indicated.
Referring to
It is understood that in a typical situation requiring venous catheterization of a patient in, for example, an emergency room or hospital, the IV infusion line 10 and the catheter 20 would be connected directly together via a releasable fluid connector, typically a Luer Lock type connector having a male portion (not shown) at a proximate end 24 of the catheter 20, and a female connector 11 portion at the proximate end 12 of the IV infusion line. The IV infusion line 10 is typically connected on the opposite, distal end to an IV therapy bag (not shown) and/or infusion pump (not shown), and a distal end 22 of the catheter 20 is inserted into a patient blood vessel, for example, in the patient's arm or hand as shown in
The illustrative embodiment of the infusion and blood collection device 100 of the present invention comprises the following main components, depicted in
Materials from which the tube holder 30, valve housing 40, shroud 70, valve 80, and retaining supports 90 can be formed, include, for example, medical grade plastics and structural polymer material such as ABS, Polyurethane, Polycarbonate, PBT, PEI, PEEK, Polypropylene, PET, and the like. For example, tube holder 30, valve housing 40, and shroud 70 can be formed from Polycarbonate and valve 80 can be formed from Polypropylene.
The intravenous infusion inlet 43 includes a separate or integrally formed male connector 42 for fluid coupling with the female connector 11, for example a Luer Lock fitting, of IV infusion line 10. The catheter head 63 includes a female connector 65, for example a Luer Lock fitting, for fluid coupling with the catheter 20. The catheter head 63 also includes an intravenous infusion microlumen 60, which is fluidly coupled to IV infusion channel 58, and a blood collection channel 54, the outlet 64 of which is fluidly coupled to catheter 20 (
Advantageously, the device 100 provides selective operation in an infusion/non-collection mode and an infusion/collection mode. As shown in
In contrast and as shown in
As shown in
As blood 18 is drawn from the vein 23 into the catheter 20, the fluid entering the collection tube 15 initially will be IV fluid 14, and then a mixture of IV fluid 14 and blood 18, and then only blood 18. Thus, the first collection tube 15 filled from the blood collection channel 54 is discarded and a subsequently filled blood collection tube 15 that contains only blood 18 and no IV fluid 14 are retained. After a sufficient sample of blood 18 is obtained from the device 100, the collection tube 15 is fluidly uncoupled from the blood collection channel 54, and if desired, subsequent collection tubes 15 are coupled, filled, and uncoupled, and then the rotary valve 80 is returned to the non-collection valve position 83a, fluidly recoupling the blood collection channel 54 with the therapy fluid 14 from the IV inlet 43, thereby again providing the infusion/non-collection mode of
Referring to
Referring to
The rotary valve 80 includes a valve member 82 that defines a valve passage 84a having openings connecting to opposite sides of the valve housing (
The draw port 81 at a bottom 77 of the septum 76 is fluidly coupled to the valve passage 84a by needle passage 84b (
Referring to
The tube holder interface 36 is configured to fit within an opening 46 in the valve housing 40 and engage with the valve 80 and housing 40 upon coupling the tube holder 30 and shroud 70 to the valve housing 40. In the first illustrative embodiment of the device 100, the engagement of the tube holder 30 with the valve housing 40 and the valve 80 provides axial positioning of the draw needle 34 and rotation of the valve 80. More specifically, the engagement axially extends the draw needle 34 through the septum bottom 77 and the needle channel 84b and into the valve passage 84a, as shown in
Referring to
The series of
Referring to
The catheter head 63 can then be attached to the catheter 20 (which, for example, has remained in the patient) by inserting the microlumen 60 all the way through the catheter 20 and tightening the Luer-type or other connector 65 onto the male catheter connector 63, thus allowing the IV therapy fluid 14 to infuse into the patient from both the catheter 20 and the microlumen 60. Advantageously, the valve housing 40 can be grasped from above and held in the palm while the release 98 is actuated, the microlumen 60 guided, and the connector 65 rotated by wing 66 all with the free thumb and/or forefinger of the hand holding the valve housing 40, freeing the other hand to apply pressure to the vein 23 to prevent blood flow through the catheter 20 from the uncoupling of the IV line connector 11 until the coupling of the device 100 connector 65. With the optionally retaining supports 90 coupled at clips 92 to valve housing receivers 94 (
Alternatively and advantageously, the device 100 can also be installed in-line with the catheter 20 upon the catheter 20 first being placed and before an IV infusion line 10 is connected to the catheter 20. For example, as described above, the device 100 can be connected to the IV infusion line 10 and flushed of air with the IV fluid 14. Then, with the device 100 prepared, the peripheral venous catheter 20 can be placed into a vein of the patient and the catheter head 63 attached to the catheter 20 as described above.
Referring now to
To prepare the device 100 for the infusion/collection mode of operation, an alcohol or other sterilizing swab is used to clean the septum 76 and the area within the opening 46 to remove any contaminates. Next the tube holder 30, without a blood collection tube 15 attached, is coupled to the valve housing 40. Specifically, the axial draw tabs 37 are rotationally aligned with the draw tab receivers 47 and the tube holder 30 is moved vertically downwards in the direction shown in
To complete the axial translation of the lower end 34b of the draw needle 34 through the septum 76 and into the valve passage 84a, the tube holder 30 is rotated clockwise relative to the valve housing 40 as shown in
Optionally, an initial length of the draw ramps 48 defined in the valve housing 40 and engaged by the draw tabs 37 can extend circumferentially without downward axially displacement in order to provide for some or all of the rotation of the valve 80 before subsequent axial translation of the interface 36 and needle 34, thus ensuring that the fluid connection between the lower needle end 34b and the valve passage 84a is not made until the valve passage 84a is closed off from the infusion channel portion 58b and thus from the supply of the IV fluid 14.
As shown in
Advantageously, the collection of blood 18 occurs simultaneous with and without interruption of infusion of IV therapy fluid 14 through infusion channel 58, exiting into the vein 23 of the patient at the distal end 62 of the microlumen 60. The collection tube 15 is uncoupled from the tube holder 30, and if desired, subsequent collection tubes 15 are coupled, filled, and uncoupled. With the lack of a vacuum, a passive fluid flow restriction provided by needle 34, and the elastomeric cover 35 again covering the upper end 34a of the needle 34, blood 18 will cease to flow through needle 34 with no collection tube 15 in place. For example, the flow restriction can be provided by the selected ID of the needle 34 as discussed further below, by crimping the needle 34 to a specific desired cross-sectional area, or by other mechanically passive means known in the art to limit flow.
To return the device 100 to the infusion/non-collection mode of operation, as shown in
Rotating the tube holder 30 counterclockwise also axially translates the interface 36 and needle 34 upwardly as the draw tabs 37 are spiraled upward within draw ramps 48. When the draw tabs 37 are again aligned with 47, the rotation is complete and interface 36 can be fully withdrawn from the opening 46 and the flanges 72 withdrawn from over the valve housing 40, as shown in
Again in the infusion/non-collection mode of operation shown in
One aspect of the first embodiment of the invention herein relates to one of the novel features of the infusion and blood collection device 100 and method, which is the ability to perform clean blood collections while simultaneously providing the patient with IV therapy infusion, without interrupting the IV fluid flow. In one aspect, the device 100 is designed so as to prevent contamination of the blood 18 being drawn with the IV fluids 14. The ability of the device 100 to provide this function is due in part to two features of the device: 1) a protrusion of the tip of the microlumen 60 in the vein 23, an optimum minimum distance beyond the tip of the catheter 20 (see
In an illustrative embodiment of these foregoing features, for example, the distal tip 62 of microlumen 60 extends 10 mm beyond the distal tip 22 of the catheter 20, paired with a restriction in the blood collection channel 54 to reduce the blood collection flow rate to 30 ml/min or less, provides sufficient protection against the IV fluids 14 flowing out from the distal tip 62 of the microlumen 60 being drawn toward and mixed in with the blood 18 being drawn into the distal tip 22 of the catheter 20 for collection in the collection tube 15.
As contemplated herein, it is to be understood that both the length of the protrusion of the tip of the microlumen relative to the tip of the catheter, and the degree of restriction of blood flow 18, may vary upward or downward depending on various factors such as, for example, the particular gauge of catheters 20 and 60 being used, the vacuum pressure in the particular collection tube 15, the venous or arterial location of the catheter 20 in the patient, and the rate of infusion of IV therapy fluid 14 out the microlumen 60. Thus, for example, with a protrusion length shorter than 10 mm, the flow rate would correspondingly have to be further restricted and decreased, and with a protrusion length longer than 10 mm, the flow rate may be increased correspondingly.
In regard to the restriction of blood flow 18 to reduce the blood collection flow rate to the point that the IV fluid flow is not reversed in the vein and drawn into the blood collection catheter, this restriction can be accomplished in various ways known in the art and at various locations along the path of the flow of the blood 18 between the distal end 22 of catheter 20 and the blood collection tube 15, either active restriction device, passive restriction device, or a combination of active and passive restriction devices. In the above illustrative embodiment of the device 100, the restriction in flow rate is made passively via the choice of the gauge of the penetration needle 34 that penetrates the end of the collection tube, thus a needle is selected having a sufficiently narrow internal diameter to provide the required limit to blood flow rate. In the illustrative device 100 with the distal end 62 of the microlumen 60 extending 10 mm beyond the distal end 22 of catheter 20, a restriction limiting the flow rate to about 30 ml/minute provides the desired lack of contamination of the blood sample collected. This desired restriction is passively provided by using a penetration needle 34 having a gauge of about 24, e.g., having an ID of about 0.3 mm (0.012 in). For example, such a needle 34 can be cut from a length of stainless steel 304 hypodermic round tubing stock, for example, part number B00137QIWS, available from Amazon.com, LLC, of Seattle, Wash.
The volume flow rate (Q) of the blood 18 is driven by the change in pressure (ΔP) for the blood 18 between the patient and the collection tube 15, and most notably in the illustrative embodiment of the device 110, at the point of passive restriction in the blood flow 18, the draw needle 34. In order to specify a needle gauge that will limit the volume flow rate (Q) to the desired magnitude, for example, about 30 ml/min or less for the illustrative embodiment, the fluid dynamic principles for laminar flow with an applied force and no-slip boundary condition between a desired blood volume flow rate (Q) and a pressure gradient (ΔP) can be used. This relationship is represented in the Hagen-Poiseuille equation which is Q=πa4ΔP/8ρμL, where a, L, ρ, μ are in this example, the interior radius and length of the needle 136, and the density and viscosity of the blood, respectively.
Referring to
The illustrative embodiment of the infusion and blood collection device 110 of the present invention comprises the following main components, depicted in
The catheter head body 202 provides fluid coupling between the microlumen 210 and blood collection lumen 150 and between the catheter 20 and the intravenous infusion lumen 160.
A blood collection channel is defined in part by the passage defined by the space between the catheter 20 and microlumen 210, the passageway 250, and the lumen 150. An infusion channel is defined in part by the microlumen 210, the passageway 260, and the lumen 160. As will be discussed in greater detail below, the blood collection channel 152 is used to provide infusion flow to the patient when the device 110 is in an infusion/non-collection mode, and, as discussed below, for reverse flow of blood 18 from the patient to the collection tube 15, when the device 110 is in an infusion/collection mode. On the other hand, the infusion channel 162 is used in either mode only for one-way infusion flow to the patient, as is discussed below.
In
Reference is made again to
Referring to
The tube holder 120 also comprises a latch actuation key 126 and an elongated, arcuate draw port interface 130, both located within the actuator receiver 124. The draw port interface 130 is positioned and sized to fit precisely into draw port interface receiver 188 upon mounting the tube holder 120 to the transfer valve and collection body 140. Likewise, latch actuation key 126 is positioned and sized to fit precisely into the latch boss receiver 186 upon mounting the tube holder 120 to the transfer valve and collection body 140. Draw port interface 130 further comprises a recessed alcohol or other disinfectant swab 134 and a needleless draw nozzle 132.
Referring now to
The housing top 144 includes an opening 146 for receiving the valve assembly central shaft 181 there through and a curved latch cantilever 147 at the distal tip of which is located a latch boss 148. The latch boss 148 cooperates with the latch boss receiver 186 of the valve actuator 184 to rotationally lock the valve assembly 180 relative to the housing 142 and elastomeric valve layer 190. The housing top 144 also includes a needleless draw port 154 from which a blood collection flow 18 is provided to the tube holder 120 during a particular operating mode described further below.
Referring now to
In contrast, selective fluid communication is provided depending on the rotational location of the valve assembly 180 and tube holder 120 relative to the transfer valve housing 142. Before mounting of the tube holder 120 to the transfer valve and collection body 140, the rotary valve 182 and valve actuator 184 are in their counterclockwise most position, shown in
Upon mounting tube holder 120 to the transfer valve and collection body 140, including full available clockwise rotation of the tube holder 120, valve actuator 184, and rotary valve 182, the infusion/collection mode of operation is provided, in which the transfer channel 183 is located in the rotation position 183b, shown in
Selection between the infusion/non-collection mode and the infusion/collection mode is provided by the mounting and clockwise rotation, and the counter-clockwise rotation and unmounting of the tube holder 120 with the transfer valve and collection body 140, including the associated function of various interoperative structures resulting from the mounting and rotation.
Upon the tube holder 120 being mounted to the transfer valve and collection body 140, the valve actuator 184 is received into the actuator receiver 124 (
In the following illustrative use of the illustrative device 110, the installation of the infusion and blood collection device 110 during intravenous therapy of a patient is described. Prior to installation of the device 110, following standard techniques well-known in the art, the peripheral venous catheter 20 is typically inserted into a vein of the patient and the IV therapy tube 10 is connected via a Luer-type or other connection 11. To install the infusion and blood collection device 110 in preparation for drawing clean blood samples from the patient via the catheter 20, the IV therapy fluid flow 14 through IV infusion line 10 is stopped, and the peripheral venous catheter 20 is disconnected from the IV infusion line 10. The transfer valve and collection body 140 of the device is connected to the IV infusion line 10 by connecting the connector 11 to the inlet port 143.
Referring to
The catheter head assembly 200 can then be attached to the catheter 20 (which, for example, has remained in the patient) by inserting the microlumen 210 all the way through the catheter 20 and tightening the Luer-type or other connector 204 onto the male connector 83, as shown in
The infusion/non-collection transfer channel position 183a functions to provide IV fluid flow 14 from the IV infusion line 10 through both the blood collection line/channel 150/152 and the IV infusion line/channel 160/162. Referring to
More specifically, and referring to
In the following illustrative use of the illustrative device 110, the use of the infusion and blood collection device 110 to draw blood 18 from the patient and into a collection tube 15 without interrupting the IV therapy of the patient is described. The device 110 is installed between IV therapy infusion line 10 and patient catheter 20 and flushed off all air as described above. A tube holder 120, disassembled from the transfer valve and collection body 140, is held in one hand, and a heat sealed tab (not shown) sealing over the blood draw port interface 130 is pulled away from the tube holder 120, exposing the interface 130, including the alcohol swab 134 and the previously sterilized draw nozzle 132.
Next, the retention wings 122 of the tube holder 120 are aligned to the keyed openings 141a of the transfer valve and collection body 140. This also aligns the draw port interface 130 with the interface receiver 188, and also aligns the latch boss receiver 186 with the latch actuation key 126. The tube holder 120 is pressed firmly into position, so that the valve actuator 184 is received into the actuator receiver 124, which presses the latch actuation key 126 into the latch boss receiver 186, deflecting the latch boss 148 (including cantilever 147) downward so that it is flush with the top surface of the housing top 144, and thus axially out from the latch boss receiver 186 so that the valve actuator 184 (including the rotary valve 182 and elastomeric valve layer 190) may rotate. In this position the draw port interface 130 is also seated within the interface receiver 188 of the valve actuator 184, thus rotating the valve actuator 184 and rotary valve 182 as the tube holder 120 is rotated clockwise relative to the housing 140.
With the latch boss 148 disengaged from the latch boss receiver 186, the tube holder 120 can be rotated clockwise relative to the transfer valve and collection body 140, rotating the retention wings 122 under the retention flanges 141b until the wings 122 reach a rotational stop (not shown), retaining the tube holder 120 in place on the transfer valve and collection body 140.
During the clockwise rotation of the tube holder 120 relative to the transfer valve and collection body 140, several critical events occur: (1) The needleless draw port 154 located on the face of the housing top 144 is drawn under the ramp 131 portion of the draw port interface 130, and across the alcohol swab 134, thus wiping and cleaning the needleless draw port 154. (2) The needleless nozzle 154 is moved into axial alignment with the needleless draw port 132, cooperating to open and seal upon the draw port 132, thus allowing collected blood 18 to flow therebetween. (3) The transfer channel 183 on the rotary valve 182 of the valve assembly 180 is rotated from the infusion/non-collection mode rotational position 183a shown in
This can be clearly seen by comparing
More specifically, and referring to
The next step in this illustrative use entails placing the collection tube 15 into the tube receptacle 128 of the tube holder 120 and pressing downward into the position shown in
Referring to
Once the desired volume of blood 18 is collected into collection tube 15, the collection tube 15 is extracted from the tube receptacle 128, and the tube holder 120 is grasped in one hand and the transfer valve and collection body 140 in the other, the tube holder 120 is rotated counterclockwise relative to the body 140 and separated therefrom. This rotation and separation rotates the valve actuator 182 and the rotary valve 184 to the counterclockwise position shown in
In regard to the restriction of blood flow 18 to reduce the blood collection flow rate to the point that the IV fluid flow is not reversed in the vein and drawn into the blood collection catheter, as with the device 100, for device 110 this restriction can be accomplished in various ways known in the art and at various locations along the blood collection channel 152, either active restriction device, passive restriction device, or a combination of active and passive restriction devices. In the above illustrative embodiment of the device 110, the restriction in flow rate is made passively via the choice of the gauge of the penetration needle 136 that penetrates the end of the collection tube, thus a needle is selected having a sufficiently narrow internal diameter to provide the required limit to blood flow rate. In the illustrative device 110 with the microlumen 210 extending 10 mm beyond the blood collection entry at catheter 20, a restriction limiting the flow rate to about 30 ml/minute provided the desired lack of contamination of the blood sample collected. This desired restriction was passively provided by using a penetration needle 136 having a gauge of about 24. In another embodiment, it is contemplated herein that the required blood collection flow restriction may be accomplished by using a tesla-type valve located anywhere along the blood collection channel 152, including located in the housing 142.
In another embodiment, it is contemplated herein that the required blood collection flow restriction may be accomplished by utilizing a check valve with a tuned reverse flow rate in lieu of a typical shut off, located anywhere along the blood collection channel 152.
In yet another embodiment, it is contemplated herein that the required blood collection flow restriction may be accomplished by utilizing a length of channel of reduced diameter to create the required restriction, located anywhere along the blood collection channel 152.
In still another embodiment, it is contemplated herein that the required blood collection flow restriction may be accomplished by having a reduction in clearance between the outside of the microlumen 210 and the inside of the catheter 20.
In still another embodiment, it is contemplated herein that the required blood collection flow restriction may be accomplished by use of a multi-lumen catheter (venous or arterial) in lieu of a typical peripheral intravenous catheter 20 and microlumen 210, but with a draw channel offset and of sufficiently small diameter and length to restrict the flow and prevent a diluted draw.
In still another embodiment, it is contemplated herein that the required blood collection flow restriction may be accomplished using an active device, which restricts the flow of the blood 18 to a collection device, located anywhere along the blood collection channel 152. Illustratively, the active device can include a pump, which draws the blood and presents the blood to the collection tube 15.
In still another embodiment, it is contemplated herein that the required blood collection flow restriction may be accomplished by having a diaphragm, needle, or other such valve actuated either by electronics or manually to create a restriction located anywhere along the blood collection channel 152.
Another embodiment of the invention herein relates to the novel feature of using a valve to segregate two or more infusion channels into a blood collection channel 152 and intravenous therapy infusion channel 162, as illustrated above. An illustrative embodiment of this feature is the use of a rotary valve as illustrated above.
In yet another embodiment, it is contemplated herein that an alternative valve type may be used. Illustratively, the valve may be a cock-stop type valve, a diaphragm type valve, an electrically actuated solenoid type valve, or a magnetic actuated valve.
In a further embodiment, described herein is a rotary blood-draw valve with locking features, as illustrated herein, to prevent access to the blood collection port by patients, for example, pediatric or agitated patients or patients suffering from various forms of dementia, or having other elevated risks relating to additional needle insertions.
In a still further embodiment, described herein is a sliding blood-draw valve with locking features, to prevent access to the blood collection port by patients, for example, pediatric or agitated patients or patients suffering from various forms of dementia, or having elevated risks relating to additional needle insertions.
In another embodiment, described herein is a collection tube holder with integrated alcohol swipe and means to clean the blood collection access port via sliding or rotating the tube holder into place prior to the draw and after the draw, as illustrated above.
It is understood that, while the illustrative embodiments of the devices 100 and 110 are directed to an angiocatheter (that is, an IV catheter), as contemplated herein, various features or combinations of features disclosed herein may be applicable to other catheters as well, such as peripherally inserted cardiac catheters, central line catheters, and the like. In the case of use with a cardiac catheter, it is understood that the required draw rate would differ because of the geometry of the vein and the blood flow rate in that region; however, the same device 110 and system can be used for controlling the blood collection rate, and a suitable protrusion length of the microlumen tip beyond the catheter tip could be easily determined and used. Additionally, it is understood that features of one of the devices 100 and 110 can be applied to the other device.
Depicted in
Materials from which the tube holder 330, valve housing 340, and rotary valve 380 can be formed include, for example, medical grade plastics and structural polymer material such as ABS, Polyurethane, Polycarbonate, PBT, PEI, PEEK, Polypropylene, PET, and the like. For example, the tube holder 330 and valve housing 340 can be formed from Polycarbonate and the rotary valve 380 can be formed from Polypropylene.
On one end of the valve housing 340, the IV inlet 343 includes a separate or integrally formed male connector (not shown) for fluid coupling with the female connector 311. On another end of the valve housing 340, a catheter head 363 connects to the valve housing 340 via a luer lock 365 for fluid coupling an IV infusion channel 358 and an IV infusion/blood collection channel 354 with the catheter 320. The luer lock 365 engages the outer surface (outer edge) of the housing 340 adjacent outlet 364.
The catheter head 363 may have an intravenous infusion microlumen 360 threaded therein or therethrough, the intravenous infusion microlumen 360 being fluidly coupled to an infusate tube 357 positioned within the IV infusion channel 358 in the valve housing 340. In some embodiments the infusate tube 357 is not required as sufficient coupling and sealing of components to sealingly form channel 358 is achieved without it. By coupling to the valve housing 340, the catheter head simultaneously couples to the hemotube 353 positioned within at least a portion of the IV infusion/blood collection channel 354, wherein the outlet 364 of the channel 354 is fluidly coupled to the catheter 320 as shown in
The rotary valve 380 includes a valve member 382 that defines a valve passage 389 having openings on the sides of the valve member 382 (see
The tube holder 330 includes a draw needle 334 and an elastomeric needle cover 335, the draw needle 334 positioned such that it pierces the needle cover 335 and the septum 376 of the infusion and blood collection system 300 as well as a vacuum collection tube 315 placed within the tube holder 330 when in use. When not in use, the tube holder can include a connectable cap 370 to prevent user injury caused by exposing the draw needle 334. The needle cover 335 illustrated in
With reference to
The microlumen 360 is in fluid communication with the infusion channel 358. The radial space between the outside surface of the microlumen 360 and the interior surface of the catheter 320 is in fluid communication with the blood collection channel 354 via outlet 364 (see
Referring to
The tube holder interfaces 336a and 336b in conjunction with the draw needle 334 couple a blood collection tube 315 to the valve housing 340. The tube holder 330 further functions to rotate the rotary valve 380 between the non-collection position 383a (see
The rotation of rotary valve 380 is provided by continued downward movement of engagement features 336a and 336b through receivers 346a and 346b contacting with ramps 348a and 348b as the tube holder 340 is manually extended axially downward and guided in rotation relative to the valve housing 340. Continued axially downward movement contacts opposing ramped surfaces of ramp 348a and engagement feature 336a and ramp 348b and engagement feature 336b, respectively, guiding rotation of engagement features 336a and 336b and rotating rotary valve member 382 via receivers 346a and 346b defined in therewith relative to valve housing 340. The corresponding locking surfaces of engagement features 336a and 336b corresponding with locking surfaces of valve housing 340 limit downward movement toward and retains tube holder 330 in position relative to the valve housing 340, thereby also retaining the rotary valve 380 position relative to valve housing 340.
Relative to the tube holder 330, the draw needle 334 extends through the tube stop 333 and has a top end 334a extending above the tube stop 333 and upwardly into the tube receptacle 332, or directly through the needle cover 335 into the blood collection tube 315 if one is connected. The draw needle 334 also extends downwardly below the tube stop 333 and has a bottom end 334b extending below the tube stop 333 and downwardly within the central area 339 (
The series of
Referring to
Referring to
When two locations are described as being “fluidly isolated,” “fluidly coupled,” “in fluid communication” or the like, as in the above paragraph, it is understood that a fluid pathway external to the device 300 can exist between the two locations. For example, while rotating rotary valve 380 to a collection position 383b as depicted in
Once blood has been collected, the collection tube 315 can be uncoupled from the tube holder 330, and if desired, subsequent collection tubes 315 can be coupled, filled, and uncoupled. With no collection tube 315 in place, the lack of a vacuum, the passive fluid flow restriction provided by the needle 334 and the additional sealing by the elastomeric cover 335 covering the upper end 334a of the needle 334, blood 318 will not flow through needle 334. The appropriate flow restriction can be provided by selecting the proper ID of the needle 334, by crimping the needle 334 to a specific desired cross-sectional area, or by other mechanically passive means to limit flow.
To return the system 300 to the infusion/non-collection configuration and the infusion/non-collection mode of operation 383a (see
Advantageously, the collection of blood 318 occurs simultaneous without interruption of infusion of IV therapy fluid 314 through infusion channel 358, exiting into the vein of the patient at the distal end 362 of the microlumen 360. The ability of the system 300 to provide this function is due in part to two features of the device: a protrusion of the tip of the microlumen 360 in the vein an optimum minimum distance beyond the tip of the catheter 320 (see
When determining the precise dimensions of the components in the infusion and blood collection device, system and/or methods 300 (or device/system/methods 100), a number of parameters can be taken into account to ensure the device/system will effectively operate in a variety of situations. These parameters include the type of patient (for example, humans (including adults, adolescents, children, and infant), canines, felines, etc.), where vein is located (arm, leg, etc.), the diameter of a typical vein being accessed, the standard venous blood superficial velocities in the vein being accessed, the densities and viscosities of the expected IV fluid, the standard blood densities and viscosities, the thickness of the microlumen wall, and the standard vacuum pressures in the blood collection device
In one example embodiment the distal tip 362 of microlumen 360 extends at least 9 mm (0.35 inches) beyond the distal tip 322 of the catheter 320, the internal diameter of needle 334 is 0.30 mm (0.012 inches), and the length of needle 334 is 3.3 cm (1.3 inches), which result in a maximum blood collection flow rate of 5 ml/min and prevents the IV fluid 314 flowing out from the distal tip 362 of the microlumen 360 from being mixed with the blood 318 being drawn into the distal tip 322 of the catheter 320 for collection in the collection tube 315. A device/system/method with these features is effective when used with a typical vein in an adult forearm with standard forearm venous blood superficial velocities, typical forearm vein diameters, IV flow rates greater than 1 ml/min, minimal Microlumen wall thicknesses, standard blood densities and viscosities, typical IV fluid densities and viscosities, and standard vacuum pressures (mmHg) from current vacuum products, for example, Vacutainers® and Vacuettes.®
In another embodiment, the distal tip 362 of microlumen 360 extends at least 3 mm (0.12 inches) beyond the distal tip 322 of the catheter 320, and the internal diameter and length of needle 334 is sized to allow a maximum blood collection flow rate of less than 5 ml/min in order to prevent the IV fluids 314 from mixing with the blood 318 being collected through catheter 320.
Additional embodiments include microlumen lengths and needle dimensions sized to draw blood without IV fluid contamination from patients and veins of different sizes, such as the arms or legs of adult, pediatric, or neonatal patients. As an example, a manufacturer can sell the device/system in three sizes, one for adult patients, one for pediatric patients, and one for neonatal patients.
The overall design of embodiments like the ones depicted in
Depending on the size of the catheter 320 being used, the microlumen 360 can occupy between 5% and 95% of the inner diameter of the catheter 320. In other embodiments, the microlumen 360 occupies between 10% and 50% of the inner diameter of the catheter 320, and in a still further embodiments the microlumen 360 occupies between 15% and 30% of the inner diameter of the catheter 320.
The size of the microlumen 360 must be sufficiently large so that when the device transitions from infusing IV fluid through both the microlumen 360 and the catheter 320 to infusing IV fluid through only the microlumen 360 (the catheter 320 being used to draw blood), the passageway through the microlumen 360 cannot create backpressure in the IV fluid that exceeds the IV pump's setting for detecting an occlusion (for example, greater than 10 psi). If the pressure in the microlumen 360 is too high when only the microlumen 360 is infusing IV fluid, the IV pump will reach its preset obstruction pressure (in essence detecting that there is an occlusion) and will automatically shut down (essentially “assuming” there is an occlusion), thereby ceasing infusion of the IV fluid into the patient and inhibiting the flushing of the blood out of catheter 320 when the healthcare provider has stopped collecting blood from the patient.
The catheter 320 in the illustrative embodiment 300 is an 18-gauge catheter, although other embodiment can include larger gauge catheters (for example 16-, 14- and 12-gauge catheters) without significantly changing (by more than 20 percent (20%)) the dimensions of the other portions of the device 300. Smaller catheters (for example, 24- and 26-gauge catheters) may also be used with the device 300 for compatibility with smaller patients (such as pre-mature infants) although the other portions of the device 300 will likely require resizing.
In regard to the restriction of blood flow 318 to reduce the blood collection flow rate to the point that the IV fluid flow is not reversed in the vein and drawn into the catheter 320 and the blood collection tube 315, this restriction can be accomplished at various locations along the flow path of the blood 318 between the distal end 322 of catheter 320 and the blood collection tube 315, either by an active restriction device (for example, a configurable valve, worm gear, or pump), a passive restriction device, or a combination of active and passive restriction devices.
In the above illustrative embodiment of the system 300, the passive restriction in flow rate is made via the choice of the gauge of the draw needle 334 that penetrates the end of the collection tube 315. A needle is selected having a sufficiently narrow internal diameter to provide the required limit to the blood flow rate. If a larger internal diameter is used, the vacuum in the blood collection tube 315 will need to be decreased (stated differently as less negative pressure, a weaker vacuum, or higher absolute pressure), the length of the needle will need to be increased (the slowing of fluid being a function of the surface area inside the needle), or a combination of both will be needed. Advantages are realized by using the entire length of the needle to slow the flow of the blood being drawn to an appropriate rate. While some embodiments can restrict the flow rate by necking or crimping methods, which produces a small aperture along a short distance in the flow direction, care must be exercised since this type of flow restriction increases the likelihood of negative effects such as damaging the blood sample (for example, hemolysis by blood shearing or other physical forces).
In the illustrative device/system/method 300 with the distal end 362 of the microlumen 360 extending, for example, about 10 mm beyond the distal end 322 of catheter 320, a restriction limiting the flow rate to about 5 ml/minute or less provides the desired lack of contamination of the blood sample collected. This desired restriction is provided by using a draw needle 334 having a gauge of about 24.
The volume flow rate (Q) of the blood 318 is driven by the change in pressure (ΔP) for the blood 318 between the patient and the collection tube 315, and most notably in the illustrative embodiment of the system 300, at the point of highest passive restriction in the blood flow 318, the draw needle 334. In order to specify a needle gauge that will limit the volume flow rate (Q) to the desired magnitude, for example, about 30 ml/min or less, or about 15 ml/min or less, or 10 mil/min or less, the fluid dynamic principles for fluid flow with an applied force and no-slip boundary condition between a desired blood volume flow rate (Q) and a pressure gradient (ΔP) can be used. In an illustrative embodiment, for example, using 1.16 inch 18 gauge catheter and a 6 ml red collection tube 315, the typical flow rate of blood 318 is observed to be about 7 ml/min.
Depicted in
As described herein, the draw needle 334 punctures the septum 376 upon connection of the tube holder 330 to the rotary valve 380 in collection mode 383b, and the septum 376 self-seals the puncture upon the decoupling of the tube holder 330 and the rotary valve 380. To achieve the self-sealing function, the septum 376 can be constructed using an elastomeric material. The septum 376 has a generally frusto-conical shape overall, including a cylindrical body 500, a planar entrance surface 375 for the draw needle 334 to enter, a planar exit surface 502 for the draw needle 334 to exit septum 376 and enter the sample chamber 377 (see
The transition surface 506 and puncture exit surface 502 collectively define the upper boundaries of the inner sample chamber 377, or dome. Advantageously, once a collection is performed by the draw needle 334 inside the sample chamber 377 and the draw needle 334 is removed from the sample chamber 377, the septum 376 promotes flushing of any residual fluid (for example, blood) remaining inside the sample chamber 377 into the IV infusion/collection channel 354 once IV fluid 314 flows back through the channel 354 when the rotary valve 380 rotates to the non-collection position 383a. In other words, the shape of the bottom of septum 376 can be configured so that IV fluid 314 rinses any residual fluid remaining in sample chamber 377 (such as fluid adhering to the walls of sample chamber 377) after the collection from the second end of the body, the end defining the sample chamber 377, and into the IV infusion/blood collection pathway 354 after the rotary valve 380 transitions from the collection position 383b to the non-collection position 383a. To promote flushing of the sample chamber 377, the sample chamber 377 may extend into less than half of the full length of the septum 376 in some embodiments. Providing the septum 376 with the sample chamber 377 for the needle 334 to be inserted is advantageous because the concave sample chamber 377 allows for the IV infusion/collection channel 354 to be narrower (that is, a smaller cross sectional diameter), and a smaller cross sectional area can lead to easier flushing. While a curved surface of the sample chamber 377 will also accept a needle 334 and promote flushing, the frusto-conical shape described herein provides the combination of space for the needle 334 and flushing capabilities.
In alternative embodiments, the septum 376 and rotary valve 380 are formed together as one continuous single-piece article. In these embodiments, the sample chamber 377 is similarly the raised portion of the valve passage 389 formed by the rotary valve 380.
To promote the collection and flushing operations described above, at least one embodiments of the sample chamber 377 has the following approximate dimensions: a diameter 508 of 5.08 mm on the top surface 375; a height 510 of 4.8 mm; a diameter 512 of 4.76 mm on the bottom surface 504; a diameter 514 of 2.54 mm at the opening of the sample chamber 377; a diameter 516 of 1.0 mm at the puncture exit surface 504 in the sample chamber 377; a depth 518 of 1.91 mm of the sample chamber 377; a surface angle 520 of 92 degrees on the body surface 500 between the top 375 and bottom 504 surfaces with respect to the normal of the top surface 375; and a surface angle 522 of 67.5 degrees on the sample chamber transition surface 506 with respect to the normal of the puncture surface 502. For example, in one embodiment the surface angle 522 is less than about 70 degrees, the ratio of diameter 514 to diameter 516 is greater than about 2.5, and the ratio of depth 518 to diameter 514 is less than about 1.0, or less than about 0.75.
The sample chamber 377 is advantageously shaped and sized to accommodate the entire edge of the draw needle (for example beveled portion 418 of draw needle 334) such that a collection may be unobstructed by any surface of the septum 376. The sample chamber 377 is also advantageously shaped and sized having a slanted (non-perpendicular) transition surface 506 with respect to the normal of the puncture surface 502 which provides resistance and thereby prevents an inversion of the sample chamber 377 when the draw needle 334 punctures the surface for one or more collections. In alternative embodiments of the sample chamber 377, the chamber 377 may be shaped as a rounded dome rather than having a frusto-conical shape. However, a rounded dome may, in some circumstances, invert as a draw needle 334 is inserted thereby obstructing the needle 334 clearance and hindering the collection.
Additionally, providing a concave lower surface for the draw needle 334 (for example, surfaces 502, 504 and 506) to collect from allows the IV infusion/collection channel 354, and ultimately the valve housing 340, to be smaller than embodiments that do not have a concave lower surface, making the sample chamber smaller and quicker to be flushed of residual body fluid by the IV fluid.
In some embodiments the sample chamber 377 defines a central axis (such as an axis extending perpendicularly from exit surface 502) that is perpendicular to the overall direction the fluid flows through valve passageway 389, which is generally parallel to the lumen in hemotube 353.
Referring now to
In the collection valve position 383b and with a vacuum collection tube mounted in tube holder 330, blood 318 flows into the rotary valve 380 via the port slit 604 and ultimately into the collection tube 315 (see
Depicted in
More specifically, the valve housing 340 includes an IV outlet 364 forming a receptacle extending outwardly and having a distal end defining a distal surface 706, wherein the distal surface 706 is a generally concave surface which can include both curved and non-curved portions. The illustrated embodiment includes a first portion 708 and a second portion 710 combining to resemble an asymmetrical funnel shape, for example, the ‘spout’ portion of which is centered on and formed by infusion/blood collection channel 354, and IV infusion channel 358 opens through a wall thereof. The first portion 708 defines a curved cross-sectional surface wherein the infusion/blood collection channel 354 extends through the valve housing 340 and terminates at the surface of the first portion 708. The second portion 710 defines a concave, convex, or planar cross-sectional surface wherein the infusion channel (housing the microlumen 360) extends through the valve housing 340 and terminates at the surface of the second portion 710.
When operating in the infusion/non-collection mode 383a, IV fluid will flow to the patient through two pathways: through the IV infusion channel 358 to the microlumen 360, and through the hemotube 353 to the catheter 320. After being switched to the infusion/collection mode 383b and with suction applied to the infusion/blood collection channel 354, IV fluid will continue to flow to the patient through the IV infusion channel 358 and the microlumen 360 while the hemotube 353 and the catheter 320 will transport bodily fluid (for example, blood) from the patient. When switching back to the infusion/non-collection mode 383a, IV fluid will continue to flow to the patient through the IV infusion channel 358 and the microlumen 360, and IV fluid will begin flowing through the infusion/blood collection channel 354, the hemotube 353 and the catheter 320 moving bodily fluid from the infusion/blood collection channel 354, sample chamber 377, the hemotube 353, and the catheter 320 into the patient. As can be appreciated by this description of the system 300 self-flushing, there is no need for the health care professional tending to the patient to flush the system 300 after drawing bodily fluid.
The shape and height of the recessed dome of sample chamber 377 influences the effectiveness of the flushing fluid (for example, IV fluid) removing the residual fluid (for example, blood) remaining inside the sample chamber. Higher domes tend to be less effective at removing the residual fluid, especially at low flow rates. However, domes that are too short or small will not provide enough clearance for the draw needle 334 to access the sample chamber.
Because of the shape of the sample chamber 377 of septum 376, IV fluid will move into all corners of the sample chamber 377 and self-flush all of the residual bodily fluid. Although the precise mechanism is not yet understood, it is believed that the sample chamber 377 of septum 376 creates eddies (and/or turbulence) in the fluid flowing through valve passage 389 as it reaches the sample chamber 377 causing the fluid to circulate near the surface 506 of the sample chamber 377 with increased velocity causing enough friction with the surface to quickly flush all of the bodily fluid into valve passage 389 and back into the patient.
Since the fluid appears to lose its ability to efficiently remove fluid from the passageway (for example, the fluid may lose a significant amount of its turbulent flow) as it moves from the sample chamber 377 and approaches the distal end 705 of the valve housing 340, the distal end 705 of the valve housing 340 is carefully shaped to efficiently remove (for example, flush) all of the bodily fluid remaining in the chamber between the end of the infusion/blood collection channel 354 and the beginning of the catheter 320 into the patient. In the embodiment illustrated in
In the embodiment illustrated in
The central axis 709 of the concave surface 706 originates at the vertex in the infusion/blood collection channel 354 and is tilted at an angle 707 in relation to the central axis 355 of the channel 354 (or in relation to the longitudinal axis of the valve housing 340. In some embodiments, angle 707 is 10 to 30 degrees and the angle between the axis 709 and the surface of concave surface 706 is 15 to 40 degrees, in other words the total included angle of the cone is approximately 30 to 80 degrees. In further embodiments, angle 707 is 15 to 25 degrees and the angle between the axis 709 and the surface of concave surface 706 is 20 to 25 degrees, in other words the total included angle of the cone is approximately 40 to 50 degrees. In still further embodiments, angle 707 is approximately 20 degrees and the angle between the axis 709 and the surface of concave surface 706 is approximately 23 degrees, in other words the total included angle of the cone is approximately 45 degrees.
Although at least one shape of concave surface 706 has been described as approximating a cone with a vertex, which can imply the sides of the cone converge at a single point, shapes in other embodiments generally resemble a cone but the surfaces do not converge at a single point and instead converge to define a line that can be straight (one dimensional) or curved in two or three dimensions. Moreover, while the concave surface 706 is generally depicted in cross-section as a straight line, which has advantages when manufacturing the device, in other embodiments the concave surface 706 is curved in cross-section. In still further embodiments, concave surface 706 is a conical section, which can have manufacturing advantages due, at least in part, to its relatively simple shape.
The IV infusion channel 358 intersects the concave end surface 706 at a location different from the location where infusion/blood collection channel 354 intersects end surface 706. In some embodiments, the position where the IV infusion channel 358 intersects the concave end surface 706 and the vertex are on opposing sides of the central axis 355 of the infusion/blood collection channel 354. Since the microlumen 360 extends through IV infusion channel 358 and into catheter 320, no fluid entering or exiting infusion/blood collection channel 354 mixes with the fluid in microlumen 360.
As discussed above, embodiments of the claimed system 300 are capable of quickly and efficiently flushing residual blood, which may remain in the catheter 320, the infusion/blood collection channel 354, or the connecting area 703 between the catheter 320 and the valve housing 340 from a blood draw and back into the patient via the catheter 320 once the system 300 is switched from the IV infusion/collection mode 383b back into the IV infusion/non-collection mode 383a. In an illustrative embodiment, a minimum rate of 10 ml/hr of IV infusion after switching from the IV infusion/collection mode sufficiently and timely flushes the system 300 to prevent residue blood from remaining in the device, including areas within the connecting area 703 partially obstructed by the microlumen 360.
Embodiments of the present disclosure include an infusion and blood collection device, system or method that includes an IV infusion line, an IV catheter, or both an IV infusion line and an IV catheter, while other embodiments include an infusion and blood collection device or system independently from an IV infusion line and an IV catheter.
Reference systems that may be used herein can refer generally to various directions (for example, upper, lower, forward and rearward), which are merely offered to assist the reader in understanding the various embodiments of the disclosure and are not to be interpreted as limiting. Other reference systems may be used to describe various embodiments, such as referring to the direction of projectile movement as it exits the firearm as being up, down, rearward or any other direction.
While examples, one or more representative embodiments and specific forms of the disclosure have been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive or limiting. The description of particular features in one embodiment does not imply that those particular features are necessarily limited to that one embodiment. Some or all of the features of one embodiment can be used in combination with some or all of the features of other embodiments as would be understood by one of ordinary skill in the art, whether or not explicitly described as such. One or more exemplary embodiments have been shown and described, and all changes and modifications that come within the spirit of the disclosure are desired to be protected.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3490441 | Curtis | Jan 1970 | A |
| 3610226 | Albisser | Oct 1971 | A |
| 3841307 | Friedell | Oct 1974 | A |
| 3958562 | Hakim et al. | May 1976 | A |
| 3983864 | Sielaff et al. | Oct 1976 | A |
| 4072146 | Howes | Feb 1978 | A |
| 4098275 | Consalvo | Jul 1978 | A |
| 4160448 | Jackson | Jul 1979 | A |
| 4665927 | Daily | May 1987 | A |
| 4822343 | Beiser | Apr 1989 | A |
| 4865583 | Tu | Sep 1989 | A |
| 5013304 | Russell et al. | May 1991 | A |
| 5122129 | Olson et al. | Jun 1992 | A |
| 5193545 | Marsoner et al. | Mar 1993 | A |
| 5250066 | Lambert | Oct 1993 | A |
| 5290246 | Yamamoto et al. | Mar 1994 | A |
| 5312361 | Zadini et al. | May 1994 | A |
| 5364374 | Morrison et al. | Nov 1994 | A |
| 5374245 | Mahurkar | Dec 1994 | A |
| 5378230 | Mahurkar | Jan 1995 | A |
| 5395319 | Hirsch et al. | Mar 1995 | A |
| 5451206 | Young | Sep 1995 | A |
| 5568806 | Cheney, II et al. | Oct 1996 | A |
| 5607401 | Humphrey | Mar 1997 | A |
| 5620008 | Shinar | Apr 1997 | A |
| 5637399 | Koshikawa et al. | Jun 1997 | A |
| 5846228 | Alexander | Dec 1998 | A |
| 5876366 | Dykstra et al. | Mar 1999 | A |
| 5891105 | Mahurkar | Apr 1999 | A |
| 5947953 | Ash et al. | Sep 1999 | A |
| 5951521 | Mastrolotaro et al. | Sep 1999 | A |
| 5954701 | Matalon | Sep 1999 | A |
| 6032059 | Henning et al. | Feb 2000 | A |
| 6146354 | Beil | Nov 2000 | A |
| 6190371 | Maginot et al. | Feb 2001 | B1 |
| 6221058 | Kao et al. | Apr 2001 | B1 |
| 6228864 | Smith et al. | May 2001 | B1 |
| 6245079 | Nobels et al. | Jun 2001 | B1 |
| 6569117 | Ziv et al. | May 2003 | B1 |
| 6758835 | Close et al. | Jul 2004 | B2 |
| 7335182 | Hilaire | Feb 2008 | B1 |
| 8348844 | Kunjan et al. | Jan 2013 | B2 |
| 8364231 | Kamath et al. | Jan 2013 | B2 |
| 8366685 | Devgon | Feb 2013 | B2 |
| 9855386 | Close et al. | Jan 2018 | B2 |
| 11141545 | Anderson | Oct 2021 | B2 |
| 20010001125 | Schulman et al. | May 2001 | A1 |
| 20010003991 | Sato et al. | Jun 2001 | A1 |
| 20010007932 | Kamen et al. | Jul 2001 | A1 |
| 20010009994 | Small et al. | Jul 2001 | A1 |
| 20010016715 | Mayer | Aug 2001 | A1 |
| 20010019019 | Nordman et al. | Sep 2001 | A1 |
| 20010020591 | Hasegawa et al. | Sep 2001 | A1 |
| 20010021429 | Nizuka et al. | Sep 2001 | A1 |
| 20010025157 | Kriesell | Sep 2001 | A1 |
| 20030149395 | Zawacki | Aug 2003 | A1 |
| 20030208154 | Close et al. | Nov 2003 | A1 |
| 20040210162 | Wyatt et al. | Oct 2004 | A1 |
| 20040236286 | Klein | Nov 2004 | A1 |
| 20050027233 | Flaherty | Feb 2005 | A1 |
| 20060189926 | Hall | Aug 2006 | A1 |
| 20070083091 | Sterling et al. | Apr 2007 | A1 |
| 20080200837 | Frazier et al. | Aug 2008 | A1 |
| 20080319346 | Crawford | Dec 2008 | A1 |
| 20090048576 | Robinson et al. | Feb 2009 | A1 |
| 20090178459 | Li | Jul 2009 | A1 |
| 20090259145 | Bartfeld | Oct 2009 | A1 |
| 20110009720 | Kunjan et al. | Jan 2011 | A1 |
| 20110160662 | Stout | Jun 2011 | A1 |
| 20110319728 | Petisce | Dec 2011 | A1 |
| 20120095369 | Teixeira et al. | Apr 2012 | A1 |
| 20120277627 | Devgon | Nov 2012 | A1 |
| 20120277630 | Devgon | Nov 2012 | A1 |
| 20130165868 | Isaacson | Jun 2013 | A1 |
| 20130178760 | Downie | Jul 2013 | A1 |
| 20140046214 | Devgon | Feb 2014 | A1 |
| 20140188002 | Close et al. | Jul 2014 | A1 |
| 20140207083 | Pessin | Jul 2014 | A1 |
| 20140276215 | Nelson | Sep 2014 | A1 |
| 20140364766 | Devgon et al. | Dec 2014 | A1 |
| 20150173663 | Teoh | Jun 2015 | A1 |
| 20150201963 | Snow | Jul 2015 | A1 |
| 20180140240 | Bullington | May 2018 | A1 |
| 20180214682 | Woehr | Aug 2018 | A1 |
| 20180304041 | Leeflang | Oct 2018 | A1 |
| 20190091462 | Bihlmaier et al. | Mar 2019 | A1 |
| 20190125236 | Hoan | May 2019 | A1 |
| 20190262599 | Nakagami | Aug 2019 | A1 |
| 20200078564 | Blanchard | Mar 2020 | A1 |
| 20200254195 | Nakagami | Aug 2020 | A1 |
| 20200352498 | Schuster | Nov 2020 | A1 |
| 20210045688 | Komada | Feb 2021 | A1 |
| 20210113811 | Nakagami | Apr 2021 | A1 |
| 20210116041 | Mermelshtein | Apr 2021 | A1 |
| 20210138162 | Nakagami | May 2021 | A1 |
| 20210299344 | Urakabe | Sep 2021 | A1 |
| 20210389215 | Gao | Dec 2021 | A1 |
| 20220257919 | Damarati | Aug 2022 | A1 |
| Number | Date | Country |
|---|---|---|
| 101573154 | Nov 2009 | CN |
| 101631498 | Jan 2010 | CN |
| 101678192 | Mar 2010 | CN |
| 2012149109 | Nov 2012 | WO |
| 2013130254 | Sep 2013 | WO |
| Entry |
|---|
| Written Opinion of the International Searching Authority for PCT/US2020/062316 dated Feb. 17, 2021. |
| Examination Report issued in CA Application No. 2.896.716 dated Aug. 21, 2019. |
| Office Action issued in Russia dated Aug. 28, 2018 for application No. 2015129013/14. |
| Written Opinion of the International Searching Authority and International Search, dated Mar. 27, 2014 for PCT/US2013/078538. |
| European Office Action for App. No. 13867172.2-1501 (dated Oct. 25, 2016). |
| Chinese Office Action for App. No. 2013800740688 (dated Aug. 18, 2016). |
| Chinese Office Action for App. No. 2013800740688 (non-certified English translation) (dated Sep. 18, 2016). |
| Office Action for Chinese App. No. 2013800740688 (dated Jun. 28, 2017). |
| Office Action for Chinese App. No. 2013800740688 (non-certification English translation) (dated Jul. 31, 2017). |
| Notice of Allowance for Chinese App. No. 2013800740688 (dated Sep. 30, 2017). |
| European Notice of Allowance for 13867172.2 (dated Dec. 20, 2017). |
| Russian Office Action for 2015129013 (dated Oct. 19, 2017). |
| “Thread”; www.merriam-webster.com/dictionary/thread; printed Mar. 16, 2016; 10 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20210154402 A1 | May 2021 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62940596 | Nov 2019 | US |
